CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Understand what to expect from financial planning and accounting services. Make informed decisions for your financial future.
23,685 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
When Anthropic faced a backlash over secret censorship in Claude Fable 5, the company apologized and promised safegua...
Morgan Stanley warns that tariff revenue may have peaked, casting doubt on a new 15% levy. Legal questions loom and h...
Mortgage rates have dropped to their lowest level since 2022, easing borrowing costs for buyers and signaling renewed...
Federal staffing declines coincide with recent terrorist incidents, prompting concerns that the u.s. faces elevated t...
A fresh study highlights a widening split among high earners. The k-shaped economy left many six-figure earners on th...
A practical finance guide inspired by the visible friendship of sarah paulson ella beatty at Broadway events. Learn h...
Lenders are turning to lifecycle lending to monetize home equity as retirees seek cash for healthcare and retirement ...
A fresh Federal Reserve briefing shows a modest emergency cushion among households, but retirement readiness remains ...
Tensions around Yemen’s Houthis could disrupt a key oil route and set off a chain reaction in markets. This guide exp...
Former President Trump claimed AI data centers should pay for their own electricity in a recent address, triggering a...
The 2026 world will bring a new advertising cadence to the World Cup, introducing mid-match hydration breaks where ad...